The National Institutes of Health, National Heart, Lung and Blood Institute, recently renewed a five-year, $1.6 million training grant at Nationwide Children's Hospital and The Ohio State University (OSU) to provide in-depth, interdisciplinary, translational and state-of-the-art research training in congenital and acquired heart disease to clinicians and basic scientists.
The program focuses on the continuum of congenital to acquired heart disease, from fetal life to senescence, and compares disease mechanisms and outcomes between these diverse populations. The rationale is that advances in heart disease therapy and prevention are most likely to originate from a translational research program that fosters collaboration between physician-scientists and basic scientists.
The funding supports an academic environment for trainees which cultivates true 'bidirectional" research, so that significant clinical problems identified by our physicians and scientists can be addressed in the laboratory, and key findings at the bench can be rapidly translated to larger animal studies and back to the bedside.
View the eligibility requirements for the Training in Congenital and Acquired Heart Disease application »